Compass Therapeutics (CMPX) Other Operating Expenses (2021 - 2022)

Compass Therapeutics has reported Other Operating Expenses for 2 years, with the latest figure at $69000.0 in Q2 2022.

• Quarterly Other Operating Expenses changed N/A year-over-year to $69000.0 in Q2 2022, while the trailing twelve-month figure through Mar 2023 was $69000.0 (changed N/A YoY) and the FY2021 annual result came in at $50.6 million, up 18113.52% from the prior year.
• Other Operating Expenses rose to $69000.0 in Q2 2022 per CMPX's latest filing, from $44000.0 in the prior quarter.
• Over five years, Other Operating Expenses peaked at $69000.0 in Q2 2022 and troughed at $44000.0 in Q1 2021.